T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 7140-7149

  Skeiky, Y A W ^a   Ovendale, P J ^a   Jen, S ^a   Alderson, M R ^a   Dillon, D C ^a   Smith, S ^a   Wilson, C B ^a   Orme, I M ^a   Reed, S G ^a   Campos Neto, A ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DNA VACCINE; MTB41 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE LIBRARY; IMMUNIZATION; MOLECULAR CLONING; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0034671804     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.7140     Document Type: Article

References (52)

1. Global challenge of tuberculosis
2. The global tuberculosis situation and the control strategy of the World Health Organization
3. Global tuberculosis incidence and mortality during 1990-2000
4. Tuberculosis a global overview of the situation today
5. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones
6. Efficacy of BCG vaccine in the prevention of tuberculosis Meta-analysis of the published literature
7. Relationship between bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis
8. The tuberculosis epidemic Scientific challenges and opportunities
9. Interferon-γ receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
10. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection
11. Major histocompatibility complex I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
12. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis
13. Characteristics of antibody response in young or thymectomized mice
14. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection
15. + T cells
16. T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis
17. Disseminated tuberculosis in interferon-γ gene-disrupted mice
18. An essential role for IFN-γ in resistance to Mycobacterium tuberculosis infection
19. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantlal protective immunity in a guinea pig model of pulmonary tuberculosis
20. Immunization of mice with mycobacterial culture filtrate proteins
21. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins
22. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate antigens
23. Protective immunity against tuberculosis by vaccination with major extracellular proteins of Mycobacterium tuberculosis
24. Mycobacterial protein antigens a compilation
25. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis
26. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis
27. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M tuberculosis
28. Nucleotide sequence of the 32 kDa-protein gene (antigen 85 A) of Mycobacterium bovis BCG
29. Evidence for glycosylation sites on the 45-kilodalton glycoprotein of Mycobacterium tuberculosis
30. Cloning, sequencing, and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigen complex
31. ESAT-6 subunit vaccination against Mycobacterium tuberculosis
32. Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis
33. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family
34. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular α antigen
35. Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis
36. + T cells
37. Leif a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile
38. Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multi-copy gene family
39. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis
40. Efficient screening of retroviral cDNA expression libraries
41. + T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice
42. + T cells requires the production of γ interferon
43. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ yet succumb to tuberculosis
44. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy requirement for T cell-deficient recipients
45. Expression cloning of a protective Leishmania antigen
46. + T cell-stimulating antigen of pathogenic bacteria by expression cloning
47. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
48. The immunogenicity of single and combination DNA vaccines against tuberculosis
49. Therapy of tuberculosis in mice by DNA vaccination
50. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
51. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
52. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family